Summary
Andrew Ng is a life-science strategy consultant and Director of Business Development with 12 years of experience bridging molecular biology, bioinformatics, and commercial strategy to accelerate pharmaceutical innovation. With a PhD from the University at Buffalo, he has deep technical expertise in proteomics, omics data analysis, and adoptive cell therapies, and translates that knowledge into evidence-based drug development and portfolio decisions for biotech and pharma clients. He has led multi-disciplinary teams to prioritize indications, forecast revenue, and de-risk early-stage assets across oncology, autoimmune, and neurological indications. Based in Penang, Malaysia, Andrew combines hands-on research credibility—having discovered novel mechanisms in bone biology—with pragmatic business development leadership at HJT Foods and prior consulting impact at Lumanity. An uncommon strength is his ability to spot model and dataset limitations from his academic work and apply those insights to better predict clinical and commercial outcomes.
12 years of coding experience
1 year of employment as a software developer
Doctor of Philosophy - PhD, Oral Biology, Doctor of Philosophy - PhD, Oral Biology at University at Buffalo
English, Chinese